Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma
Open Access
- 22 February 2022
- journal article
- research article
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2022, 1-13
Abstract
Statistical reports on non-Hodgkin’s lymphoma (NHL) of the head and neck combining clinical medicine with pathology are rare. To provide a basis for prognosis prediction and individualized treatment, we will investigate the clinicopathologic characteristics and prognosis of lymphoma in the head and neck region. Four hundred sixty-one patients with NHL in the head and neck region diagnosed through histological biopsy were retrospectively analyzed. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) were performed in all cases to evaluate the genetic status and protein expression levels. Patients were followed up by telephone. The prevalence rate of primary extranodal NHL (PENHL) in the head and neck region was 44.62% (166/372). The incidence of extranodal lymphoma accounted for 36.66% (169/461) of all head and neck lymphomas. Among the cases of PENHL of the head and neck, diffuse large B-cell lymphoma (DLBCL) (60/76, 78.95%) and extranodal NK/T-cell lymphoma, nasal type (ENKTCL) (21/24, 87.5%) were the most common subtypes originating from B-cell lymphoma (BCL) and T-cell lymphoma (TCL), respectively. The most common sites of nodal and extranodal onset were neck lymph nodes and the gastrointestinal tract, respectively. The most common and primary locations of BCL and TCL were the tonsils and nasal cavity, respectively. The 3-year survival rates of PENHL, ENKTCL, and DLBCL of the head and neck were 42%, 28.57%, and 41.67%, respectively, and the 5-year survival rates were 24%, 19.05%, and 20%, respectively. Survival analysis showed that male sex was a risk factor ( ; 95% CI, 1.164-25.267; ) and that comprehensive treatment was a protective factor ( ; 95% CI, 0.025-0.545; ) against extranodal DLBCL in the head and neck region. Bone marrow involvement was a risk factor for PENHL of the head and neck ( ; 95% CI, 1.17-21.991; ). The purpose of this review is to show that PENHL of the head and neck with high incidence deserves more attention, and a model of multidisciplinary diagnosis and treatment should be adopted.Keywords
Funding Information
- Cisco-Roche Tumor Research Foundation (Y-Roche 2019/2-0061, 81660036)
- National Natural Science Foundation of China (Y-Roche 2019/2-0061, 81660036)
This publication has 41 references indexed in Scilit:
- Distribution of Lymphoid Neoplasms in ChinaAmerican Journal of Clinical Pathology, 2012
- Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 StudyJournal of Clinical Oncology, 2012
- Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK/T-Cell Lymphoma, Nasal Type, With EBV Subtyping AnalysisAmerican Journal of Surgical Pathology, 2011
- Head and neck non-Hodgkin's lymphoma: a 20-year demographic study of 381 casesInternational Journal of Oral and Maxillofacial Surgery, 2010
- National Cancer Database report on cancer of the head and neck: 10‐Year updateHead & Neck, 2009
- Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2008
- Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 PatientsClinical Cancer Research, 2007
- Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid TissueThe Oncologist, 2006
- New Treatment Options Have Changed the Survival of Patients With Follicular LymphomaJournal of Clinical Oncology, 2005
- Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic IndexInternational Journal of Oral and Maxillofacial Surgery, 2005